Trademark Overview
On Tuesday, January 30, 2024, a trademark application was filed for NELSON+ with the United States Patent and Trademark Office. The USPTO has given the NELSON+ trademark a serial number of 79401595. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, September 5, 2024. This trademark is owned by Institute for DiagNostic. The NELSON+ trademark is filed in the Advertising, Business and Retail Services, Computer & Software Products & Electrical & Scientific Products, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:
Conducting of educational seminars and e-learning with respect to research procedures for screening and early detection of illnesses, including screening and early detection of lung cancer, heart and vascular diseases and COPD; publication of the results of clinical trials.
Application software for screening and early detection of illnesses, including screening and early detection of lung cancer, heart and vascular diseases and COPD; software for use in the implementation of screening and early detection of illnesses; management information system software [MIS] for screening and early detection of illnesses, including radiological protocols required for this screening and detection; computer software for database management; computer software for the creation of searchable databases of information and data; computer programmes for data processing.
Data management services for hospitals and screening centres for screening and early detection of illnesses, including screening and early detection of lung cancer, heart and vascular diseases and COPD; management and compilation of computerised databases; compilation and systematisation of information in databanks, with particular attention to radiological protocols and radiological images and measurements that are done in images, which are necessary for an effective screening and the early detection of illnesses, including lung cancer, heart and vascular diseases and COPD; office services for electronically processing, collecting and collating data, not related to insurance, financial affairs, monetary affairs of real estate affairs.
Development of software for data conversion from and to different protocols for screening and early detection of illnesses, including screening and early detection of lung cancer, heart and vascular diseases and COPD; design, development and implementation of software; installation, maintenance and updating of database and biobank software; development, updating and maintenance of software and database systems; advisory services relating to scientific research and medical research in the field of screening and early detection of lung cancer, heart and vascular diseases and COPD; medical research, in particular medical research in the field of screening and early detection of lung cancer, heart and vascular diseases and COPD.
